Theseus Pharmaceuticals picks up $100m Series B

Theseus Pharmaceuticals, a biotechnology company, has raised $100 million in Series B financing.

13 April 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles